Otonomy to Present at the Bank of America Merrill Lynch Health Care Conference
May 10, 2017 16:05 ET
|
Otonomy, Inc.
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
Otonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 04, 2017 16:27 ET
|
Otonomy, Inc.
SAN DIEGO, May 04, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
Otonomy to Report First Quarter 2017 Financial Results and Provide Corporate Update
April 27, 2017 16:05 ET
|
Otonomy, Inc.
SAN DIEGO, April 27, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
March 02, 2017 16:18 ET
|
Otonomy, Inc.
Topline data for OTO-104 Phase 3 trials in Ménière’s disease expected in 2H2017 Implemented changes to commercial organization to improve OTIPRIO® sales performance Company to host conference call...
Otonomy to Present at Cowen and Company Health Care Conference
February 28, 2017 16:05 ET
|
Otonomy, Inc.
SAN DIEGO, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss
January 19, 2017 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Provides Corporate and Product Pipeline Update
January 09, 2017 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy to Present at the J.P. Morgan Healthcare Conference
January 03, 2017 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy Appoints Kathie M. Bishop, Ph.D., as Chief Scientific Officer
November 30, 2016 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Otonomy to Present at Piper Jaffray Healthcare Conference
November 22, 2016 16:05 ET
|
Otonomy, Inc.
SAN DIEGO, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...